The shortage of ADHD medication in the UK has caused long waiting times in the NHS ...

People with ADHD are spending thousands of pounds on treatment and medication, with more than 400,000 private prescriptions ...

The drugs are listed in alphabetical order. Adalimumab-Adbm injection: Boehringer Ingelheim Pharmaceuticals discontinued two presentations of Cyltezo, its biosimilar to Humira. The injectable ...

The Drug Enforcement Administration (DEA ... DEA Administrator Anne Milgram noted that there have been shortages of ADHD medicines, including Adderall, since 2022, adding: “Any diversion ...

The Royal Australian College of GPs is urging the New South Wales Government to prioritise reforms to improve access to support and treatment for ...

“The analysis highlights a clear shortage of research on ADHD in adulthood, particularly regarding medium-term [beyond 12 weeks] and long-term treatment outcomes. Consequently, the findings are ...

“The analysis highlights a clear shortage of research on ADHD in adulthood, particularly regarding medium-term (beyond 12 weeks) and long-term treatment outcomes, consequently, the findings are ...

Adults with attention-deficit/hyperactivity disorder (ADHD) who use an extended-release medication are more likely to ...

In recent years, the NHS has faced numerous drug shortages, with serious consequences for both patients and healthcare professionals.12 These ongoing shortages have affected a wide range of drugs, ...

“If you look at the current guidelines on the management of ADHD in the UK,” Cortese said, “they recommend medication as the first line. They also mention non-pharmacological treatment if ...